Drug-Coated Balloons for Coronary Interventions: A Focused Review
Authors
Discussion
Loading...
Member takes
Implication
This review explores drug-coated balloons for managing in-stent restenosis and coronary artery disease, suggesting their potential benefits.
Key Points
- Drug-coated balloons significantly reduce the need for permanent metallic implants, improving treatment outcomes for coronary artery disease patients.
- Early studies indicate DCBs demonstrate comparable efficacy to drug-eluting stents, especially in complex cases involving high-risk patients.
- The review highlights the evolving role of DCBs in addressing issues related to in-stent restenosis and de novo coronary disease.
- Challenges include the potential for coronary dissection and optimal preparation for lesion treatment, necessitating further investigation.
Cite This Study
Patel et al. (2025) studied this question.